Author: OurCrowd

[Alpha Tau in PR Newswire] Alpha Tau announces completion of enrollment of Japanese pivotal clinical trial in recurrent head & neck cancer

Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its clinical trial partner in Japan, that recruitment has been completed in its open-label multi-center pivotal study evaluating the Alpha DaRT in Japanese patients with recurrent Head & Neck cancer after radiotherapy. Read more...

Read More

[Aria Pharmaceuticals in Pulmonary Fibrosis News] Top 10 pulmonary fibrosis stories of 2021

Pulmonary Fibrosis News brought you daily coverage throughout 2021 of the latest scientific findings, treatment developments, and clinical trials related to pulmonary fibrosis (PF). As a reminder of what mattered most to you during the past year, here are the top 10 most-read articles of 2021, with a brief description of what made them interesting and relevant to the PF community. Read...

Read More